Dr. Reddy's Q4 Net Profit Drops 86% YoY

Board approved audited FY26 results with Q4 revenue of ₹75.16B, down 11.6% YoY, and net profit of ₹2.20B, down 86% YoY.
Recommended a final dividend of ₹8 per share for FY26, with a record date of July 10, 2026, subject to shareholder approval.
Approved re-appointment of Dr. K P Krishnan and appointment of Mr. Srikanth Velamakanni as Independent Directors for five-year terms.
Appointed Deloitte Haskins & Sells as Statutory Auditors and elevated Mr. Sandeep Khandelwal to Senior Management Personnel.